Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Profound Medical Corp(PROF)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for PROF
11/09/2026: PROF (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Profound Medical Corp is a medical technology company focused on providing non-invasive, image-guided prostate therapy using its TULSA-PRO platform. The company's primary strength lies in its ability to offer an incision-free alternative to traditional prostate surgery, which is a significant value proposition for patients concerned with side effects. Its main growth story is centered on increasing physician adoption and expanding insurance reimbursement coverage for its procedure. However, the company faces stiff competition from major medical device incumbents and must manage the financial risks associated with scaling a high-growth technology firm. Investors should monitor progress in reimbursement adoption and clinical data, noting that the stock remains suitable for those with higher risk tolerance.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company provides exposure to disruptive medical technology in a large, under-penetrated market. |
| Momentum investor | Strong fit while signal remains positive | This stock may appeal to momentum investors during periods of regulatory or commercial adoption acceleration. |
| Value investor | Weak fit | Profound Medical is currently focused on growth and market penetration rather than profitability or value metrics. |
| Dividend investor | Weak fit | The company does not pay dividends and requires capital for ongoing commercial expansion. |
| Low-risk investor | Weak fit | The company is a high-growth, high-volatility medical technology firm, which does not fit a conservative profile. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | Small-cap medtech stocks are subject to significant price swings based on clinical news and market sentiment. |
| Valuation risk | Medium / high | Valuation is sensitive to long-term growth assumptions and clinical success rates. |
| Competition risk (Surgical Robotics) | High | Established incumbents have significant resources to protect their share of the prostate treatment market. |
| Business quality | Medium | While the technology is innovative, the company is still building its commercial franchise and recurring revenue streams. |
| Dividend income | Low / none | Investors should not expect income from this investment. |
| Execution risk | High | The company must successfully scale its sales force and navigate complex reimbursement landscapes to achieve profitability. |
Price Behavior
Rolling Over
The price momentum is slowing down and beginning to turn downward.
Highly Choppy
The stock has experienced frequent, large price swings that make its near-term movement less predictable.
Analysis of Past Performance
Type Stock | Historic Profit -19.39% | Avg. Invested days 30 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/09/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 264.08M USD | Price to earnings Ratio - | 1Y Target Price 11.14 |
Price to earnings Ratio - | 1Y Target Price 11.14 | ||
Volume (30-day avg) 302.6K shares | Beta 0.56 | 52 Weeks Range 4.80 - 8.95 | Updated Date 11/08/2026 |
52 Weeks Range 4.80 - 8.95 | Updated Date 11/08/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.99 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Capital Equipment Sales | Revenue from the initial sale or installation of TULSA-PRO and Sonalleve systems. | This is the 'razor' part of the business; it provides the footprint for future revenue. |
| Recurring Disposables | Revenue from the sale of single-use components required for each procedure performed. | This is the 'blade' part of the business; it drives high-margin growth as procedure volume increases. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE - | Enterprise Value 234.27M | Price to Sales(TTM) 13.84 |
Enterprise Value 234.27M | Price to Sales(TTM) 13.84 | ||
Enterprise Value to Revenue 10.95 | Enterprise Value to EBITDA -5.75 | Shares Outstanding 36.63M | Shares Floating 35.50M |
Shares Outstanding 36.63M | Shares Floating 35.50M | ||
Percent Insiders 4.09 | Percent Institutions 45.41 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.